Acquired resistance mechanisms to osimertinib: The constant battle
Cancer Treatment Reviews · 2023-05 · 116 · 102557
DOI: 10.1016/j.ctrv.2023.102557 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2023-05. Verfasst von Ziad Zalaquett und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology-Oncology, Hôtel-Dieu de France University Hospital, Saint Joseph University of Beirut, Beirut, Lebanon. Electronic address: …. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 100-mal zitiert (Crossref) und nennt 144 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology-Oncology, Hôtel-Dieu de France University Hospital, Saint Joseph University of Beirut, Beirut, Lebanon. Electronic address: ziadzalaquett@gmail.com.
- Department of Hematology-Oncology, Hôtel-Dieu de France University Hospital, Saint Joseph University of Beirut, Beirut, Lebanon.
- Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
Zitieren
APA
Zalaquett, Z., Catherine Rita Hachem, M., Kassis, Y., Hachem, S., Eid, R., Raphael Kourie, H., & Planchard, D. (2023). Acquired resistance mechanisms to osimertinib: The constant battle. Cancer Treatment Reviews, 116, 102557. https://doi.org/10.1016/j.ctrv.2023.102557
Vancouver
Zalaquett Z, Catherine Rita Hachem M, Kassis Y, Hachem S, Eid R, Raphael Kourie H, et al. Acquired resistance mechanisms to osimertinib: The constant battle. Cancer Treatment Reviews. 2023;116:102557. doi:10.1016/j.ctrv.2023.102557
BibTeX
@article{Zalaquett2023,
author = {Zalaquett, Ziad and Catherine Rita Hachem, Maria and Kassis, Yara and Hachem, Samir and Eid, Roland and Raphael Kourie, Hampig and Planchard, David},
title = {Acquired resistance mechanisms to osimertinib: The constant battle},
journal = {Cancer Treatment Reviews},
year = {2023},
volume = {116},
pages = {102557},
doi = {10.1016/j.ctrv.2023.102557}
}
EUVIMED